Pichai Raman
Pichai Raman
Oncology, Data Strategy & Design Director at GSK
Verified email at
Cited by
Cited by
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
J Barretina, G Caponigro, N Stransky, K Venkatesan, AA Margolin, S Kim, ...
Nature 483 (7391), 603-607, 2012
Activation of a metabolic gene regulatory network downstream of mTOR complex 1
K Düvel, JL Yecies, S Menon, P Raman, AI Lipovsky, AL Souza, ...
Molecular cell 39 (2), 171-183, 2010
Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 ImmunotherapyAlternative Splicing of CD19 Enables Resistance to CART-19
E Sotillo, DM Barrett, KL Black, A Bagashev, D Oldridge, G Wu, ...
Cancer discovery 5 (12), 1282-1295, 2015
The landscape of genomic alterations across childhood cancers
SN Gröbner, BC Worst, J Weischenfeldt, I Buchhalter, K Kleinheinz, ...
Nature 555 (7696), 321-327, 2018
Integrated molecular meta-analysis of 1,000 pediatric high-grade and diffuse intrinsic pontine glioma
A Mackay, A Burford, D Carvalho, E Izquierdo, J Fazal-Salom, KR Taylor, ...
Cancer cell 32 (4), 520-537. e5, 2017
Comprehensive analysis of hypermutation in human cancer
BB Campbell, N Light, D Fabrizio, M Zatzman, F Fuligni, R de Borja, ...
Cell 171 (5), 1042-1056. e10, 2017
Calcium-activated chloride channel ANO1 promotes breast cancer progression by activating EGFR and CAMK signaling
A Britschgi, A Bill, H Brinkhaus, C Rothwell, I Clay, S Duss, M Rebhan, ...
Proceedings of the National Academy of Sciences 110 (11), E1026-E1034, 2013
The membrane protein data bank
P Raman, V Cherezov, M Caffrey
Cellular and Molecular Life Sciences 63 (1), 36-51, 2006
CASC15-S Is a Tumor Suppressor lncRNA at the 6p22 Neuroblastoma Susceptibility LocusCASC15 Is a Neuroblastoma Suppressor Gene
MR Russell, A Penikis, DA Oldridge, JR Alvarez-Dominguez, L McDaniel, ...
Cancer research 75 (15), 3155-3166, 2015
Molecular, pathological, radiological, and immune profiling of non-brainstem pediatric high-grade glioma from the HERBY phase II randomized trial
A Mackay, A Burford, V Molinari, DTW Jones, E Izquierdo, ...
Cancer cell 33 (5), 829-842. e5, 2018
Identification of GPC2 as an oncoprotein and candidate immunotherapeutic target in high-risk neuroblastoma
KR Bosse, P Raman, Z Zhu, M Lane, D Martinez, S Heitzeneder, KS Rathi, ...
Cancer cell 32 (3), 295-309. e12, 2017
Transcriptome analysis of IL-10-stimulated (M2c) macrophages by next-generation sequencing
EB Lurier, D Dalton, W Dampier, P Raman, S Nassiri, NM Ferraro, ...
Immunobiology 222 (7), 847-856, 2017
Selective inhibition of TGFβ1 activation overcomes primary resistance to checkpoint blockade therapy by altering tumor immune landscape
CJ Martin, A Datta, C Littlefield, A Kalra, C Chapron, S Wawersik, ...
Science translational medicine 12 (536), eaay8456, 2020
Genomic profiling of childhood tumor patient-derived xenograft models to enable rational clinical trial design
JL Rokita, KS Rathi, MF Cardenas, KA Upton, J Jayaseelan, KL Cross, ...
Cell reports 29 (6), 1675-1689. e9, 2019
Enrichment of targetable mutations in the relapsed neuroblastoma genome
OM Padovan-Merhar, P Raman, I Ostrovnaya, K Kalletla, KR Rubnitz, ...
PLoS genetics 12 (12), e1006501, 2016
Crizotinib Synergizes with Chemotherapy in Preclinical Models of NeuroblastomaCrizotinib and Chemotherapy Synergize in Neuroblastoma
K Krytska, HT Ryles, R Sano, P Raman, NR Infarinato, TD Hansel, ...
Clinical Cancer Research 22 (4), 948-960, 2016
Englerin A agonizes the TRPC4/C5 cation channels to inhibit tumor cell line proliferation
C Carson, P Raman, J Tullai, L Xu, M Henault, E Thomas, S Yeola, J Lao, ...
PloS one 10 (6), e0127498, 2015
A LIN28B-RAN-AURKA signaling network promotes neuroblastoma tumorigenesis
RW Schnepp, P Khurana, EF Attiyeh, P Raman, SE Chodosh, ...
Cancer cell 28 (5), 599-609, 2015
The Myc-miR-17-92 axis amplifies B-cell receptor signaling via inhibition of ITIM proteins: a novel lymphomagenic feed-forward loop
JN Psathas, PJ Doonan, P Raman, BD Freedman, AJ Minn, ...
Blood, The Journal of the American Society of Hematology 122 (26), 4220-4229, 2013
Integrated proteogenomic characterization across major histological types of pediatric brain cancer
F Petralia, N Tignor, B Reva, M Koptyra, S Chowdhury, D Rykunov, A Krek, ...
Cell 183 (7), 1962-1985. e31, 2020
The system can't perform the operation now. Try again later.
Articles 1–20